The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10962542 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 30, 2021

Filed:

Sep. 10, 2015
Applicant:

Metabolomycs, Inc., Long Beach, CA (US);

Inventors:

Andre Lopes Carvalho, Barretos, BR;

Rene Aloisio Da Costa Vieira, Barretos, BR;

Ismael Dale Cotrim Guerreiro Da Silva, Sao Paulo, BR;

Edson Guimaraes Lo Turco, Sao Paulo, BR;

Therese Koal, Innsbruck, AT;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); G01N 33/68 (2006.01); G01N 33/92 (2006.01); A61B 5/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57415 (2013.01); A61B 5/41 (2013.01); G01N 33/57484 (2013.01); A61B 5/00 (2013.01); G01N 33/6812 (2013.01); G01N 33/92 (2013.01); G01N 2333/71 (2013.01); G01N 2333/90 (2013.01); G01N 2570/00 (2013.01); G01N 2800/50 (2013.01); G01N 2800/52 (2013.01); Y10T 436/24 (2015.01);
Abstract

A metabolic biomarker set for use in assessing, screening, and/or diagnosing breast cancer in a mammalian subject includes at least (a) one amino acid selected from glutamine, glutamate and serine, and one lipid, or (b) glutamine and glutamate. Described further, is a metabolic biomarker set for prediction of therapeutic response to breast cancer neoadjuvant chemotherapy; a metabolic biomarker set for assessing biochemical reflection of breast cancer tumor activity; and a metabolic biomarker set for subclassification between intrinsic breast cancer tumor subtypes. Moreover, a method for assessing breast cancer is described, which includes obtaining a biological sample, preferably blood, from a mammalian subject and measuring in the biological sample the amount and/or ratios of metabolites. By employing the specific biomarkers and the method it becomes possible to more properly and reliably assess breast cancer.


Find Patent Forward Citations

Quick Actions:

Lopes Carvalho, Andre. (2021). Biomarkers for assessing breast cancer (U.S. Patent No. 10962542). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10962542

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…